Skip to main content
Not Found
Digital Seminar

COVID-19 Treatments

FDA Approved & Off Label Medications

Speaker:
Karen Morrissey, PhD, FNP, BC
Duration:
1 Hour 59 Minutes
Format:
Audio and Video
Copyright:
Mar 25, 2022
Product Code:
POS078436
Media Type:
Digital Seminar


Description

Karen Morrissey PhD, FNP, BC works as a telemedicine family nurse practitioner in a COVID-19 Initiative, delivering care to many patients experiencing COVID symptoms. As guidance continually evolves, this session will cover the latest effective treatment options regarding:

  • Patient self-assessment
  • Risk group priority tiers
  • FDA approved treatments
  • Off label treatments

Credit



Handouts/Brochure

Speaker

Karen Morrissey, PhD, FNP, BC's Profile

Karen Morrissey, PhD, FNP, BC Related seminars and products


Karen Morrissey, PhD, FNP, BC, works as a telemedicine family nurse practitioner in a COVID-19 Initiative, delivering care to many patients experiencing COVID symptoms. She brings a wealth of experiences, drawing from roles in PACU, home care, pre-op and correctional nursing. Karen earned her FNP degree from the University of Connecticut and her PhD in Nursing from Walden University.


Speaker Disclosures:
Financial: Karen Morrissey has employment relationships with CVS Minute Clinic and Post University. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Karen Morrissey is a member of the American Association of Nurse Practitioners.


Additional Info

Access for Self-Study (Non-Interactive)

Access never expires for this product.


Questions?

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info


Objectives

  1. Assess severity of symptoms to develop the most appropriate plan of care.
  2. Evaluate current FDA approved COVID treatments for use in outpatient clinics.
  3. Analyze non-FDA approved medications and understand why they are not yet approved.
  4. Determine outpatient treatments that should be avoided.

Outline

As guidance continually evolves, learn from a real time discussion on the latest effective treatment options:
  • Patient self-assessment 
  • Symptom rating
  • Risk group priority tiers
  • FDA approved treatments by symptom
  • Off label treatments
  • Tixagevimab-Cigavimab Evusheld
  • Monoclonal antibody therapy
  • Casiriviman/imdevimab
  • Sotrovimab
  • Bamlaniviman-etesevimab
  • Remdesivir veklury
  • Nirmatrelvir-ritonavir Paxlovid
  • Molnupiravir
  • Outpatient therapies that should be avoided

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physicians Assistants

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://cdn.pesi23.com/images/android.png     https://cdn.pesi23.com/images/iphone.png

Please wait ...

Back to Top